{
    "title": "Roche-PTC Therapeutics' oral spinal muscular atrophy drug wins FDA approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8605467/FDA-approves-oral-spinal-muscular-atrophy-drug-Roche-PTC-Therapeutics.html",
    "date": "2020-08-07",
    "keywords": [
        "evrysdi",
        "price",
        "atrophy",
        "therapy",
        "year",
        "singh",
        "drug",
        "administration",
        "treatment",
        "genentech",
        "pricing",
        "muscular",
        "disease",
        "food",
        "roche",
        "ag",
        "ptc",
        "risdiplam",
        "gene",
        "weight",
        "patient",
        "kg",
        "age",
        "maximum",
        "unit",
        "statement",
        "infant",
        "spokesperson",
        "capital",
        "analyst",
        "surprise",
        "list",
        "evrysdis",
        "novartis",
        "onetime",
        "cause",
        "body",
        "protein",
        "development",
        "zolgensma",
        "form",
        "threat",
        "process",
        "delivery",
        "express",
        "pharmacy",
        "foundation",
        "bell",
        "reporting",
        "manojna",
        "maddipatla",
        "shivani",
        "bengaluru",
        "john",
        "miller",
        "switzerland",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}